论文部分内容阅读
目的探讨布地奈德混悬液雾化吸入在小儿支气管哮喘治疗中的疗效。方法选择2013年9月-2014年4月医院收治的支气管哮喘患儿120例,随机分为观察组与对照组各60例,对照组给予抗感染、止咳平喘、维持酸碱平衡及吸氧等对症基础治疗;观察组在对照组基础上加用布地奈德混悬液雾化吸入。对比2组患儿咳喘症状、肺部哮鸣音消失情况、住院天数及治疗有效率。结果观察组患儿咳喘症状、肺部哮鸣音消失、住院天数等指标显著短于对照组,差异有统计学意义(P<0.05);观察组总有效率93.3%显著高于对照组的78.3%,差异有统计学意义(P<0.05);2组患儿在治疗过程中均未见明显不良反应。结论儿童支气管哮喘常规治疗同时联合布地奈德雾化吸入,疗效确切且安全可靠,具有较高的临床应用价值。
Objective To investigate the efficacy of inhalation of budesonide suspension in the treatment of pediatric bronchial asthma. Methods 120 cases of bronchial asthma admitted to our hospital from September 2013 to April 2014 were randomly divided into observation group (60 cases) and control group (60 cases). The control group was given anti-infective, cough and asthma maintenance, acid-base balance and oxygen And other symptomatic treatment; observation group on the basis of the control group plus budesonide suspension inhalation. Compared two groups of children with cough and asthma symptoms, disappearance of lung wheeze, hospitalization days and treatment efficiency. Results The cough and asthma symptoms, disappearance of lung wheeze, days of hospitalization and other indexes in the observation group were significantly shorter than those in the control group (P <0.05). The total effective rate in the observation group was significantly higher than that in the control group 78.3%, the difference was statistically significant (P <0.05); two groups of children in the course of treatment were no significant adverse reactions. Conclusions The routine treatment of children with bronchial asthma combined with budesonide inhalation, definitive and safe and reliable, with high clinical value.